Combination of the new minor groove alkylator tallimustine and melphalan

European Journal of Cancer Part A

Volumn 33, Issue 2, 1997, Pages 284-287

  Tagliabue, G ^a   Filippini, C ^a   Ubezio, P ^a   D'Incalci, M ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Alkylating drug; Antineoplastic agent; In vivo; Melphalan; Mouse tumours; Tallimustine

Indexed keywords

ALKYLATING AGENT; MELPHALAN; TALLIMUSTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA L 1210; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOSARCOMA;

EID: 0030930916     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00435-2     Document Type: Article

References (16)

1. Kohn KW. Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. Cancer Res 1977, 37, 1450-1454.
2. Erickson LC, Laurent G, Sharkey NA, Kohn KW. DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature 1980, 288, 727-729.
3. Zwelling LA, Anderson T, Kohn KW. DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxiciry. Cancer Res 1979, 39, 365-369.
4. Sessa C, Pagani O, Zurlo MG, et al. Phase I study of the novel distamycin derivative tallimustine (FCE 24517). Ann Oncol 1994, 5, 901-907.
5. Broggini M, Erba E, Ponti M, et al. Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Res 1991, 51, 199-204.
6. Hartley JA, Forrow SM, Souhami RL. Effect of ionic strength and cationic DNA affinity binders on the DNA sequence selective alkylation of guanine N7-positions by nitrogen mustards. Biochemistry 1990, 29, 2985-2991.
7. Grimaldi KA, McAdam SR, Souhami RL, Hartley JA. DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells. Nucleic Acids Res 1994, 22, 2311-2317.
8. Sariban E, Kohn KW, Zlotogorski C, et al. DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone. Cancer Res 1987, 47, 3988-3994.
9. Coley HM, Mongelli N, D'Incalci M. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents. Biochem Pharmacol 1993, 45, 619-626.
10. II-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo. Cancer Res 1988, 48, 94-100.
11. Mattes WB, Hartley JA, Kohn KW. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucleic Acids Res 1986, 14, 2971-2987.
12. Ponti M, Forrow SM, Souhami RL, D'Incalci M, Hartley JA. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Res 1991, 19, 2929-2933.
13. Teicher BA, Holden SA, Eder JP, Herman TS, Antman KH, Frei E. Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination. Semin Oncol 1990, 17, 18-32.
14. D'Incalci M, Citti L, Taverna P, Catapano CV. Importance of the DNA repair enzyme 06-alkyl guanine alkyltransferase (AT) in cancer chemotherapy. Cancer Treat Rev 1988, 15, 279-292.
15. Reynolds VL, Molineux IJ, Kaplan DJ, Swenson DH, Hurley LH. Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity. Biochemistry 1985, 24, 6228-6237.
16. Broggini M, Coley HM, Mongelli N, et al. DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin. Nucleic Acids Res 1995, 23, 81-87.